CoChat
Sign Up
Cited by 29Pharmacogenetics and Drug MetabolismPharmaceutical Practices and Patient OutcomesPharmacy and Medical Practices

The DOI matches its Crossref record.

The Role of Hospital Pharmacists in the Adoption and Use of Pharmacogenomics and Precision Medicine

Schwartz, Emily J, Issa, Amalia M·2017·Personalized Medicine
DOI 10.2217/pme-2016-0063
Open this paper in CoChat — free account

Abstract

AIM: Our aim was to assess the knowledge and attitudes of US hospital pharmacists about the implementation of clinical pharmacogenomics, and examine liability risks of adopting pharmacogenomics by pharmacists. METHODS: We surveyed hospital pharmacists. Linear regression models of predictor variables for pharmacist adoption and use of pharmacogenomics were analyzed. RESULTS: The survey was administered to 660 hospital pharmacists (23% response rate; n = 149). The majority of respondents (72%) favor implementing pharmacogenomics into pharmacy practice. However, only 25% are confident in their abilities to interpret pharmacogenomic test results. CONCLUSION: Pharmacists lack confidence in their abilities to interpret and use pharmacogenomic information in clinical care. These results raise potential liability risks that are pertinent to pharmacists.

Overview

Integrity signals

Registry

Crossref · 10.2217/pme-2016-0063

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 64

  1. 10.2217/pgs.13.59 · DOI
  2. 10.1038/clpt.2013.72 · DOI
  3. 10.1038/clpt.2014.101 · DOI
  4. 10.1002/ajmg.c.31390 · DOI
  5. 10.1038/clpt.2011.371 · DOI
  6. 10.1002/ajmg.c.31396 · DOI
  7. 10.1002/ajmg.c.31391 · DOI
  8. 10.1016/j.mayocp.2013.10.021 · DOI
  9. 10.1038/clpt.2014.137 · DOI
  10. 10.1002/ajmg.c.31385 · DOI
  11. 10.2146/ajhp100113 · DOI
  12. 10.1097/GIM.0b013e318238b38c · DOI
  13. 10.1124/pr.112.007252 · DOI
  14. 10.1007/s40256-013-0024-5 · DOI
  15. 10.3389/fphar.2015.00061 · DOI
  16. 10.1371/journal.pgen.1004978 · DOI
  17. 10.2174/1389200215666140130124910 · DOI
  18. 10.1136/amiajnl-2013-001873 · DOI
  19. 10.1038/clpt.2012.117 · DOI
  20. 10.1038/clpt.2012.140 · DOI
  21. Crews KR , HicksJK , PuiC-H , RellingMV , EvansWE . Pharmacogenomics and individualized medicine: Translating science into practice . Clin. Pharmacol. Ther.92 ( 4 ), 467 – 475 ( 2012 ).
  22. 10.2217/pme.13.85 · DOI
  23. 10.1331/JAPhA.2014.13041 · DOI · Paper page
  24. 10.4140/TCP.n.2013.696 · DOI
  25. 10.2146/ajhp140613 · DOI
  26. 10.1016/j.ijmedinf.2015.11.015 · DOI
  27. 10.1002/phar.1481 · DOI
  28. 10.1038/nbt0410-299 · DOI
  29. Frick A , BentonCS , ScolaroKLet al. Transitioning pharmacogenomics into the clinical setting: training future pharmacists . Front. Pharmacol.7 ( 241 ), 1 – 11 ( 2016 ).
  30. 10.1331/JAPhA.2012.12108 · DOI
  31. 10.1146/annurev.pharmtox.010909.105805 · DOI
  32. 10.1126/scitranslmed.3001067 · DOI
  33. 10.1002/PHAR.1039 · DOI
  34. 10.1331/JAPhA.2011.10178 · DOI
  35. 10.1331/JAPhA.2011.11543 · DOI
  36. 10.1038/tpj.2013.33 · DOI
  37. 10.2217/pgs.14.109 · DOI
  38. 10.2217/pgs-2016-0002 · DOI
  39. 10.2217/pgs.13.76 · DOI
  40. 10.1038/clpt.2014.185 · DOI
  41. 10.2146/sp150003 · DOI
  42. Feldman HL . Pushing drugs: genomics and genetics, the pharmaceutical industry, and the law of negligence . Washburn Law J.42 ( 3 ), 575 – 599 ( 2003 ).
  43. 10.1038/gim.2012.13 · DOI
  44. 10.3390/jpm5020067 · DOI
  45. 10.5455/jcme.20150408050414 · DOI · Paper page
  46. Schwartz E , IssaAM . A national survey of pharmacists’ roles in clinical pharmacogenomics: assessment of predictors . Presented at : 31st International Society for Pharmacoepidemiology . Boston, MA, USA , 23–26 August 2015 .
  47. 10.1038/clpt.2013.59 · DOI
  48. 10.1186/s13073-015-0200-0 · DOI
  49. 10.1038/clpt.2012.125 · DOI
  50. 10.1038/clpt.2010.279 · DOI
  51. 10.2217/pme.14.62 · DOI
  52. 10.2147/PGPM.S63715 · DOI
  53. 10.1111/j.1399-0004.2012.01908.x · DOI
  54. 10.2217/pme.11.28 · DOI
  55. 10.1038/clpt.2011.306 · DOI
  56. 10.5688/ajpe75351 · DOI
  57. 10.5688/ajpe77110 · DOI
  58. 10.2217/pgs.15.50 · DOI
  59. 10.1007/s11606-011-1651-7 · DOI
  60. 10.1038/gim.2011.15 · DOI
  61. 10.1038/gim.2013.69 · DOI
  62. 10.3122/jabfm.2014.02.130104 · DOI
  63. Garbutt BJ , HofmannME . Recent developments in pharmaceutical products liability law: failure to warn, the learned intermediary defense, and other issues in the new millennium . Food Drug Law J.58 ( 2 ), 269 – 286 ( 2003 ).
  64. Dwyer P . The duty of the pharmacist and the pharmaceutical industry . Med. Law.22 ( 3 ), 495 – 516 ( 2003 ).

Cited by

Sorted by citations

See all 29

Metadata

Authors
Schwartz, E. J., & Issa, A. M.
Affiliations
University of the Sciences (US)
ORCID
Issa, Amalia M
Venue
Personalized Medicine
Publisher
Informa UK Limited
Published
2016-10-19
Volume
14
Issue
1
Pages
27-35
ISSN
  • 1741-0541 (ISSN-L)
  • 1744-828X
DOI
10.2217/pme-2016-0063
OpenAlex
W2537685776
Cited by
29
References
0
Citations by year
2026: 1 · 2025: 1 · 2024: 7 · 2023: 2 · 2022: 2 · 2021: 4 · 2020: 5 · 2019: 3 · 2018: 2 · 2017: 2
FWCI
2.96
Type
journal article
Language
en
Open access
closed
Locations
  • Personalized Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Human Genome Research Institute (NHGRI) of the NIH (R01 HG006145)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
  • Health Sciences › Health Professions › Pharmacy › Pharmacy and Medical Practices
Keywords
pharmacogenomics, hospital pharmacists, precision medicine, pharmacist knowledge and attitudes, liability risk, pharmacy practice
MeSH terms
Adult, Female, Hospitals, Humans, Health Knowledge, Attitudes, Practice, Male, Middle Aged, Pharmacists, Pharmacogenetics, Surveys and Questionnaires, Professional Role, Precision Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Role of Hospital Pharmacists in the Adoption and Use of Pharmacogenomics and Precision Medicine. https://app.cochat.ai/papers/10.2217/pme-2016-0063
The paper
Schwartz, E. J., & Issa, A. M. (2017). The Role of Hospital Pharmacists in the Adoption and Use of Pharmacogenomics and Precision Medicine. Personalized Medicine. https://doi.org/10.2217/pme-2016-0063